| Anthem Blue Cross | Products for Wound Healing and Soft Tissue Grafting: Investigational | 2026-04-01 |
| Anthem Blue Cross | Mobile Device-Based Health Management Applications | 2026-04-01 |
| Anthem Blue Cross | Transanal Irrigation | 2026-04-01 |
| Anthem Blue Cross | Ankle-Foot & Knee-Ankle-Foot Orthoses | 2026-04-01 |
| Anthem Blue Cross | Therapeutic use of Stem Cells, Blood and Bone Marrow Products | 2026-04-01 |
| Anthem Blue Cross | Auditory Brainstem Responses (ABRs) and Evoked Otoacoustic Emissions (OAEs) for Hearing Disorders | 2026-04-01 |
| Anthem Blue Cross | Gene Therapy for Spinal Muscular Atrophy | 2026-04-01 |
| UHC UMR Medical and Drug | Cardiovascular Disease Risk Tests – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Category III Codes – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Denosumab – Commercial Medical Benefit Drug Policy | 2026-04-01 |